Piedmont Cancer Institute - Atlanta is a clinical research site located in Atlanta, Georgia, United States 30318.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Piedmont Cancer Institute - Atlanta has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Positive, Metastatic Hormone-sensitive Prostate Cancer.
Sponsors: Gilead Sciences, Bayer.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Piedmont Cancer Institute - Atlanta has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Piedmont Cancer Institute - Atlanta has 2 clinical trials on record, with 2 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Positive, Metastatic Hormone-sensitive Prostate Cancer.
Piedmont Cancer Institute - Atlanta has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.